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Perioperative Cardiac Events in Endovascular Thoracoabdominal An-
eurysm Repair: Association with preoperative studies and long term
prognosis
Tara M Mastracci, Roy Greenberg. The Cleveland Clinic Foundation,
Cleveland, OH
Objectives: Cardiac complications are common following repair of
thoracoabdominal aneurysms. Endovascular repair obviates the need for
aortic cross-clamping, large incisions, and marked fluid shifts, yet has still
been associated with significant cardiac morbidity. This study was under-
taken to evaluate cardiac morbidity following endovascular thoracoabdomi-
nal aneurysm repair.
Methods: A single-center trial over a 5 year period included all patients
who underwent thoracoabdominal aneurysm repair with branched devices
was reviewed to evaluate cardiac complications within 30 days of implanta-
tion, including: STEMI, NSTEMI (including troponin 0.1), and fatal
arrhythmias. Preoperative characteristics (echocardiographic results, func-
tional testing, and cardiac related symptoms) were compared using univar-
iate analyses, and independent risk factors for perioperative cardiac events
were determined using a multivariate analysis. Analyses were also performed
to determine association between perioperative rise in troponin and long
term death.
Results: In total, 395 patients underwent endovascular thoracoab-
dominal repair in the period between 2003 and December 2007. Post
operative troponin levels peaked to 0.1 ng/mL in 12% (33/268) of the
patients. The mean peak troponin was 0.5 ng/mL (SD 0.51) in this subset
of patients, most commonly on post operative day 4 (SD 1.54). There were
2 cardiac-related death (both with troponin levels 0.1, 2/33, 6%) in the
perioperative period. Of the patients that had cardiac complications, 30 had
echocardiography documented and 5 had cardiac catheterizations preoper-
atively.
Conclusions: Lethal cardiac complications are uncommon follow-
ing endovascular thoracoabdominal aneurysm repair. However, troponin
levels (in excess of 0.1 ng/mL) are relatively common indicating that
there may remain a significant cardiac risk. The optimal preoperative
testing paradigm remains to be determined and should the subject of
further evaluation.
Author Disclosures: T.M. Mastracci, Cook Medical, Inc; R. Greenberg,
CookMedical, Inc; Gore; Terarecon; CookMedical Inc; CookMedical Inc.
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Age Related Trends in Abdominal Aortic Aneurysms: Repairs, Rup-
ture, and Death Rates in the United States Medicare Population
Kristina A Giles1, A James O’Malley2, Philip Cotterill3, Frank B Pom-
poselli1, Bruce E Landon2, Marc L Schermerhorn1. 1Beth Israel Deaconess
Medical Center, Boston, MA; 2Harvard Medical School, Boston, MA;
3Centers for Medicare and Medicaid Services, Baltimore, MD
Objective: Recently the UK and ADAM small AAA trials showed that
repair could safely be deferred in small AAA. EVAR has allowed safer elective
AAA repair. We evaluated total AAA related mortality over the time period
inclusive of these landmark events.
Methods: All US Medicare beneficiaries undergoing AAA repair,
intact (iAAA) or ruptured (rAAA), or hospitalized for rupture without
repair from 1996-2006 were identified. Event rates per 100,000 benefi-
ciaries were compared in the young (65-74) and elderly (75) between
1996 and 2006.
Results: iAAA decreased in the young but increased in the elderly
(Table). In 2006 more iAAA were EVAR in the elderly (71%) than young
(64%). Despite the increased rate of repair in the elderly, the population
death rate from iAAA decreased more in the elderly than the young. AAA
ruptures and rupture deaths decreased in both groups but more so in the
elderly. Overall AAA related deaths have decreased in all Medicare benefi-
ciaries but more so in the elderly. Despite this, the AAA related death rate of
those over 74 is still 3 times that of those 65-74.
Conclusions: AAA rupture is decreasing in the young despite the
deferral of elective AAA repair suggesting a decreasing incidence of AAA.
EVAR has lowered the operative risk of iAAA while repair has expanded
in the elderly. EVAR has likely allowed treatment of patients previously
considered unfit for OAR yet still at risk for rupture. Total AAA related
deaths are decreasing likely due in part to expanded treatment in the
elderly with lower operative mortality with EVAR as well as lower
incidence of AAA.Rates of intact and ruptured AAA repairs, AAA rupture,
and AAA-related deaths
1996 2006 Absolute change
Rates (per
100,000)*
75
Years
75
Years
75
Years
75
Years
75
Years
75
Years
75
Years
75
Years
Intact
Repair
93.9 92.3 82.3 112.4 12 20 P  .001 P  .001
Rupture
Diagnosis
(with or
without
repair)
20.0 34.1 9.4 20.8 11 13 P  .001 P  .001
Rupture
Repair
14.6 19.9 6.4 10.3 8 10 P  .001 P  .001
Death
Rates
All AAA-
Related
12.9 30.3 5.7 17.3 7 13 P  .001 P  .001
Intact
Repair
3.6 6.9 1.7 3.8 2 3 P  .001 P  .001
Rupture
Diagnosis
(with or
without
repair)
9.3 23.4 4.0 13.6 5 10 P  .001 P  .001
Rupture
Repair
5.6 11.0 2.1 5.0 3 6 P  .001 P  .001
*Rates adjusted for gender.
Age-stratified mortality rates in 1996 and 2006 after open
AAA repair and EVAR
Repair
mortality 1996 2006 Absolute change
Open and
EVAR
75
Years
75
Years
75
Years
75
Years
75
Years
75
Years
75
Years
75
Years
Intact Repair 3.8% 7.5% 2.1% 3.4% 1.8% 4.2%P  .001P  .001
Rupture
Repair
38.4% 55.4% 32.8% 48.5% 5.5% 6.9%P  .01P  .001
Open
Intact Repair 3.8% 7.5% 4.0% 7.4% 0.2% 0.1% P 
.40
P 
.75
Rupture
Repair
38.4% 55.4% 34.5% 51.4% 3.9% 4.0%P  .05P  .05
EVAR
Intact Repair 1.0% 1.7%
Rupture
Repair
23.6% 36.2%
Author Disclosures: K.A. Giles, None; A. O’Malley, None; P. Cotterill,
None; F.B. Pomposelli, None; B.E. Landon, Gore Unrestricted Educational
Grant;M.L. Schermerhorn,GoreUnrestricted Educational Grant; Endologix
DSMB Grant.
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Duplex Scanning After Infrainguinal Endovascular Therapy for Criti-
cal Limb Ischemia
Mistydawn Humphries, William C Pevec, John R Laird, Jr., Khung K Yeo,
Nasim Hedayati, David L Dawson. University of California, Davis, Sacra-
mento, CA
Objective: Duplex ultrasound scanning (DUS) has benefit for evalua-
tion of surgical bypasses in the lower extremities. The utility of DUS with
endovascular revascularizations is not established. This study was performed
to evaluate whether DUS findings after infra-inguinal endovascular inter-
ventions for critical limb ischemia (CLI) were predictive of need for early
reintervention or patients’ amputation-free survival.
Methods: To identify the study cohort, peripheral interventions for
CLI (Rutherford grades 4,5,6) over a 24 month period (2006-2007) were
reviewed. DUS findings were considered abnormal if the peak systolic
velocity (PSV) was 180 cm/s or the PSV velocity ratio was 2.0. Demo-
graphic, clinical, procedural, and outcomes were examined. SVS and TASC
II classifications and reporting standards were used. Arteriograms were
reviewed and treated segments were categorized as patent (30% residual
stenosis) or abnormal (30% residual stenosis).
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Volume 49, Number 5S Rapid Paced Paper Sessions 51SResults: There were 144 infra-inguinal interventions for CLI in 114
patients (52 % male; mean age 68.8 y); 123 limbs were treated. Treated
segments were TASC II C or D, or had severe infra-popliteal disease in 68%.
Risk factors included diabetes: 25%; renal failure: 11%; smoking (within 1 y):
23%.Mortality at 12 months was 16.7%; with a preceding major amputation in
4 of 19. DUSwas performed within 30 days of the index procedure in 90 cases.
A normal DUS finding was associated with better limb salvage (p  0.06).
Abnormal early DUS findings were noted after 26 CLI interventions that had
no demonstrated residual abnormality with completion angiography (47%).
LIMBS WITH CRITICAL LIMB ISCHEMIA
Analysis per limb treated: Outcomes at 12 months for patients with DUS within 30 days
Lost to
follow-up
(n  24)
Primary
patency
(%)
Reinter-
ventions
(n)
Secondary
patency
(%)
Open
revasc-
ularization
(n)
Amputation
n (%)
Normal DUS
(n  40)
4 70.1 6 88.9 2 2 (5.6)
Abnormal DUS
(n  50)
2 46.2 13 71.8 3 10 (20.1)
Conclusions: DUS detects residual stenoses missed with angiography
after CLI interventions. An abnormal DUS within 30 days after an interven-
tion was associated with increased risk of treatment failure (need for second-
ary procedures, limb loss). This suggests a role for intra-procedural DUS, as
well as routine post-procedure DUS, close clinical follow up, and consider-
ation of re-intervention for residual abnormalities.
Author Disclosures: M. Humphries, None; W.C. Pevec, None; J.R.
Laird, None; K.K. Yeo, None; N. Hedayati, None; D.L. Dawson, None.
RR17.
Predictors of Failure and Success of Tibial Interventions for Critical
Limb Ischemia
Nathanial Fernandez, Ryan McEnaney, Luke Marone, Robert Rhee, Steven
Leers, Michel Makaroun, Rabih Chaer. University of Pittsburgh Medical
Center, Pittsburgh, PA
Objective: The efficacy of tibial artery endovascular intervention
(TAEI) for critical limb ischemia (CLI) and particularly wound healing
remains to be fully determined.
Methods: All TAEIs for tissue loss or rest pain (Rutherford 4/5/6) from
2004-2008 were reviewed. Clinical outcomes and patency rates were analyzed
by multivariable Cox proportional hazards regression and life table analysis.
Results: 123 limbs in 111 patients (62% male, mean age 74) underwent
TAEI. 102 limbs (83%) had tissue loss. All interventions included tibial angio-
plasty (PTA) with selective atherectomy (17 %); 20% of limbs underwent
interventions on 1 tibial vessel. 50 limbs (41%) underwent isolated tibial
procedures while 73 had concurrent ipsilateral SFA or popliteal intervention.
The mean distal popliteal and tibial runoff score improved from 11.8 3.6 to
6.7  1.6 and the mean ABI increased from 0.61  0.26 to 0.85  0.22. 5
patients (4%) required bypass. One-year primary, primary-assisted and second-
ary patency rates were 33%, 50% and 56% respectively. Limb salvage rate at
one-year was 75% (table). TAEI in an isolated peroneal artery (OR 7.80,
p0.01) was associated with impaired wound healing, whereas multilevel
intervention (HR2.1, p0.009) and tibial laser atherectomy (HR3.1,
P0.01) were predictors of wound healing. In patients with tissue loss, 41%
achieved complete closure (mean time to healing 10.77.4 months) and 39%
improved (mean FU 4.4  4.8 months) at last follow up. Diabetes, smoking,
statin therapy, and revascularization of1 tibial had no impact on limb salvage
or wound healing. Re-intervention rate was 50% at 1 year (.table) and was
unaffected by prior atherectomy.
Conclusions: TAEI is an effective treatment for CLI with acceptable
limb salvage and wound healing. Multiple tibial vessel revascularization has
no impact on limb salvage but debulking is associated with improved wound
healing. Patients with renal failure, pedal disease or isolated peroneal runoff
have poor results with TAEI and should be considered for pedal bypass.
HR 95% CI p-value
Limb Loss
Renal failure 5.73 1.16-28.24 0.03
CABG 3.42 1.13-10.33 0.03
Dorsalis Pedis Intervention 13.75 1.08-174.74 0.04
Reintervention
Peroneal intervention 3.41 1.61-7.25 0.001
Dorsalis Pedis Intervention 6.91 0.84-56.95 0.07
Multilevel intervention 2.45 1.06-4.78 0.036Author Disclosures: N. Fernandez, None; R. McEnaney, None; L.
Marone, None; R. Rhee, None; S. Leers, None; M. Makaroun, None; R.
Chaer, None.
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Comparable Limb Salvage, Patency and Survival Rates Following Open
and Endovascular Revascularizations in African Americans
Hasan HDosluoglu1, Purandath Lall1, Linda MHarris2, Maciej L Dryjski2.
1VAWesternNYHealthcare System, SUNY at Buffalo, Buffalo, NY; 2SUNY
at Buffalo, Buffalo, NY
Objective African Americans (AA) have been reported to have poorer
early and late patency and limb salvage (LS) rates following bypass proce-
dures. The goal of this study is compare the results of AA and Caucasians
(CAU) who present with symptomatic peripheral arterial disease (PAD).
Methods All AA and CAU patients who presented with symptomatic
PAD between 06/2001-06/2008 were included.
Results Of the 698 patients (799 limbs), 93 were AA, and 706 were
CAU. AA were more likely to be non-ambulatory, have poorer functional
capacity (4 METS), renal failure, dialysis-dependence, lower albumin
levels and present with gangrene, whereas CAU had more CAD, hyperlip-
idemia, and COPD (Table I). Significantly more AA had primary amputa-
tion (PA, 14% vs 6%, P0.001). Of those who underwent revascularization,
62% and 61% in AA and CAU groups had endovascular procedures. Infrap-
opliteal and multilevel interventions were significantly more frequent in AA
(Table I). Perioperative morbidity and mortality were similar. Patency rates,
limb salvage and survival were similar in AA and CAU who underwent
revascularization (Table II). Multivariate analysis showed diabetes, gan-
grene, infrapopliteal interventions and functional capacity independently
predicted limb loss, whereas race did not.
Conclusions Among patients presenting with symptomatic PAD, AA
patients were more likely to have poorer functional status, renal failure, present
with gangrene and have lower albumin levels than CAU patients, and were
more likely to undergo PA. However, survival, limb salvage and patency rates
were similar following open and endovascular revascularizations, although AA
were more likely to have infrapopliteal and multilevel interventions.
Table I. Differences between groups for comorbidities,
and clinical presentation.
AA Caucasian P
CAD 46% 62% 0.005
DM 54% 49% 0.0378
Hyperlipidemia 58% 71% 0.011
COPD 14% 26% 0.001
Renal insuff/dialysis 40%/19% 25%/6% 0.003
4 METS/non-
ambulatory
60%/21% 48%/16% 0.036
DC/ Gangrene/
foot sepsis
11%/43%/5%32%/27%/1% 0.001
Infrapop/multilevel 51%/51% 27%/30% 0.001
Albumin 3.00.6 3.40.7 0.001
Table II. Patency, limb salvage and survival rates for AA
and Caucasians with different types of int
PP
(12mo)
PP
(36mo)
SP
(12mo)
SP
(36mo)
LS
(12mo)
LS
(36mo)
Survival
(12mo)
Survival
36mo)
AA
(n80)
805% 667% 865% 815% 805% 785% 785% 666%
CAU
(n664)
722% 643% 871% 792% 862% 783% 802% 612%
P 0.891 0.984 0.528 0.727
AA EV
(n50)
826% 679% 925% 876% 876% 827%* 796% 589%**
CAU
(n406)
802% 673% 922% 852% 872% 794% 812% 613%
P 0.913 0.709 0.887 0.634
AA, open
(n30)
758% 6410% 778% 729% 719% 719%* 768% 738%**
CAU open
(n258)
733% 594% 813% 714% 853% 764% 883% 623%
P 0.944 0.832 0.312 0.420
*P0.190 (AA EV vs open LS).
**P0.471 (AA EV vs open survival).
